eli lilly retatrutide phase 3 trial watchlongevity.com | Lilly's experimental obesity drug hit its primary goal in a large trial, with participants losing roughly Starting Phase 3 Clinical Trial

While meta-analyses suggest a slight association between semaglutide and cholelithiasis, they do not indicate an increased risk of pancreatitis or pancreatic cancer (42)

JAMA 2025;333:113-4

She then developed blurred vision in her right eye

Critics argue its especially dissonant given her own history of nearly dying twice once from a pulmonary embolism after stepping on broken glass, once from a traumatic C-section recovery experiences that exposed the structural failures of American healthcare, particularly for Black women

Ozempic Manufacturers Response to NAION Allegations Novo Nordisk, like many other pharmaceutical companies that have faced backlash for not disclosing serious health risks, has pushed back against such claims

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis